Nicolab is rolling out AI-powered Stroke software “StrokeViewer” to 12 Hospitals in Queensland Health

February 23, 2023
By Brenda Dubois

One in six people will likely to have a stroke at some point in their life. Starting stroke treatment just a few minutes earlier can be the difference between life and death.

Nicolab will roll out a six-month trial of StrokeViewer, an artificial intelligence-powered mobile stroke diagnostics tool across 12 Brisbane Queensland hospitals in early 2023.

The trial sites are: Royal Brisbane and Women’s Hospital; The Prince Charles Hospital; Caboolture; Redcliffe; Sunshine Coast University Hospital; Gympie; Hervey Bay; Bundaberg; Rockhampton; Mackay; Townsville; and Cairns Base Hospital.

StrokeViewer is a certified comprehensive, end-to-end solution, supporting clinicians with the most accurate diagnosis, decision making and treatment planning tools available for patients presenting with a stroke. StrokeViewer allows clinicians to make critical, life-saving decisions anywhere and anytime via its unique mobile app.

Stroke is a devastating disease where blood supply to the brain is stopped, initiating cell death and severe brain damage within minutes. The solution will provide all hospitals with a common platform and may significantly reduce the time required for each step in the stroke workflow.

Prof Andrew Wong StrokeViewer
A/Prof Andrew Wong using StrokeViewer

A/Prof Andrew Wong, co-chair of the Queensland Stroke Clinical Network and RBWH Director of Neurology and Stroke said stroke is one of Australia’s biggest killers.

“With figures showing one in six people will have a stroke at some point in their life, Queensland Health is investing into this crucial technology that will help improve the outcomes of patients who have had a stroke across QLD.”

The project will address the major gap of access to stroke care in regional and remote locations. Regardless of geographical location, CT brain images from acute stroke patients will be sent immediately to city-based stroke physicians to diagnose the type of stroke that has occurred – within minutes. 

Nicolab’s Australian-based Chairman, Paul Lappin, says “with such a devastating and time-critical disease, StrokeViewer provides patients with the best chances of living the life they deserve. The only clinically certified stroke diagnostic viewer allows informed decision-making when it’s all about time.”

In stroke care, starting treatment just a few minutes earlier can be the difference between life and death. In the time interval from hospital arrival to endovascular procedure start, every 1 second of delay has been associated with a loss of 2.2 hours of healthy life*. The StrokeViewer solution will address mounting pressure on emergency healthcare professionals, placing real technology to support treatment decisions in the physician’s hands.

Headquartered in Amsterdam, Nicolab is an Australian-based publicly unlisted company. Nicolab has a growing team of sales and specialists based in Australia, as well as company directors, executives and the majority (75%) of shareholders.

For further information please contact:

Belinda Hughes (Metro North Health)


Felicity Frederico (Nicolab)



Stay up to date and subscribe